Business
Cardax and GNC Sign Mutual Exclusivity Agreement for ZanthoSyn®
Cardax and GNC Sign Mutual Exclusivity Agreement for ZanthoSyn®.
About this update from Cardax Inc
[{"type":"text","content":"\n\n\n\nCardax and GNC Sign Mutual Exclusivity Agreement for ZanthoSyn®\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prnsbls{\nBORDER-LEFT:black 1pt solid\n}\n.prntblns{\nBORDER-TOP: 1pt; BORDER-RIGHT: 1pt; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt\n}\n.prnsbbs{\nBORDER-BOTTOM:black 1pt solid\n}\n.prnvab{\nVERTICAL-ALIGN: BOTTOM\n}\n.prnrbrs{\nBORDER-RIGHT:black 1pt solid\n}\n.prnpl6{\nPADDING-LEFT:0.50em\n}\n.prnsbts{\nBORDER-TOP:black 1pt solid\n}\n.prnpr6{\nPADDING-RIGHT:0.50em\n}\n\n\n\n\n\n\nCardax and GNC Sign Mutual Exclusivity Agreement for ZanthoSyn®\nExclusivity for Brick-and-Mortar Channel Strengthens National Marketing\nPR Newswire\nHONOLULU, Oct. 20, 2017\n\n\n\nHONOLULU, Oct. 20, 2017 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) announced today that it has entered into a mutual exclusivity agreement with General Nutrition Corporation (\"GNC\") for ZanthoSyn, the Company's premium astaxanthin dietary supplement for inflammatory health and longevity.*\n\nThe exclusivity agreement builds on the Company's recently announced national rollout of ZanthoSyn across GNC's more than 3,200 US corporate stores and now designates GNC as the exclusive \"brick-and-mortar\" retailer of ZanthoSyn in the United States. ZanthoSyn will also continue to be available online at gnc.com, amazon.com, and zanthosyn.com.\n\nThe exclusivity agreement covers the use of ZanthoSyn as a human dietary supplement, with an initial term of two years and provides for automatic renewals.\n\nThe exclusivity obligation is subject to GNC continuing to stock ZanthoSyn across all of its US corporate stores and GNC not selling a competing house-branded astaxanthin dietary supplement (synthetic or natural) or a competing synthetic astaxanthin dietary supplement from other vendors.\n\n\"We are delighted with this mutual exclusivity agreement,\" said David G. Watumull, Cardax CEO. \"Our growing relationship with GNC builds on the exceptional sales of ZanthoSyn in Hawaii GNC stores and will leverage GNC's more than 10,000 person in-store sales force to actively market ZanthoSyn across...